Results
|
|
1.
|
Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials. MedStar authors:
Year: 2015
Citation: - Antimicrobial Agents & Chemotherapy. 59(2):1119-26, 2015 Feb.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Anzueto AR, File TM, Huang X, Lodise TP, Shorr AF, Smith A, Weber DJ, Yang M, Zhao Q
|
|
|
2.
|
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. MedStar authors:
Year: 2021
Citation: - The Lancet Infectious Diseases. 21(2):213-225, 2021 02.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Matsunaga Y, Menon A, Nagata TD, Pogue JM, Shorr AF, Timsit JF, Wunderink RG, Zeitlinger M
|
|
|
3.
|
|
